The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemia^a

• Henry Nording,
• Lasse Baron,
• Antje Lübken,
• Hossein Emami,
• Jacob von Esebeck,
• Moritz Meusel,
• Christian Sadik,
• Nancy Schanze,
• Daniel Duerschmied,
• Jörg Köhl,
• Götz Münch,
• Harald F. Langer

Affiliations

Henry Nording

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany

Lasse Baron

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany

Antje Lübken

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany

Hossein Emami

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany

Jacob von Esebeck

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany

Moritz Meusel

Medical Clinic II, University Hospital, University Heart Center Lübeck, Lübeck, Germany

Christian Sadik

Clinic for Dermatology, University of Lübeck, University Hospital, Lübeck, Germany

Nancy Schanze

Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Daniel Duerschmied

Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Jörg Köhl

ISEF, University of Lübeck, Lübeck, Germany

Götz Münch

AdvanceCOR, Martinsried, Germany

Harald F. Langer

Cardioimmunology Group, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany